Does ILOPROST Cause Therapy cessation? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Therapy cessation have been filed in association with ILOPROST (AURLUMYN). This represents 0.2% of all adverse event reports for ILOPROST.
10
Reports of Therapy cessation with ILOPROST
0.2%
of all ILOPROST reports
1
Deaths
4
Hospitalizations
How Dangerous Is Therapy cessation From ILOPROST?
Of the 10 reports, 1 (10.0%) resulted in death, 4 (40.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ILOPROST Alternatives Have Lower Therapy cessation Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT